Exploring the Immunological Mechanisms Underlying the Anti-vascular Endothelial Growth Factor Activity in Tumors

por de Aguiar, Rodrigo Barbosa, de Moraes, Jane Zveiter
Publicado 2019

Anti‐bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor‐binding response, impairing tumor outgrowth

por Sanches, Jéssica de Souza, de Aguiar, Rodrigo Barbosa, Parise, Carolina Bellini, Suzuki, Juliana Mayumi, Chammas, Roger, de Moraes, Jane Zveiter
Publicado 2016

Potential of an anti-bevacizumab idiotype scFv DNA-based immunization to elicit VEGF-binding antibody response

por Silva, Tábata Almeida, Aguiar, Rodrigo Barbosa, Mori, Marcelo, Machado, Gabriel Esquitini, Hamaguchi, Barbara, Machado, Marcelo Ferreira Marcondes, Moraes, Jane Zveiter
Publicado 2022

Impaired proliferation and migration of HUVEC and melanoma cells by human anti-FGF2 mAbs derived from a murine hybridoma by guided selection

por Georg Magalhães, Carolina, Ploeger Mansueli, Carla, Manieri, Tânia Maria, Quintilio, Wagner, Garbuio, Angélica, de Jesus Marinho, Juan, de Moraes, Jane Zveiter, Tsuruta, Lilian Rumi, Moro, Ana Maria
Publicado 2023

Hybridoma technology: is it still useful?

por Moraes, Jane Zveiter, Hamaguchi, Bárbara, Braggion, Camila, Speciale, Enzo Reina, Cesar, Fernanda Beatriz Viana, Soares, Gabriela de Fátima da Silva, Osaki, Juliana Harumi, Pereira, Tauane Mathias, Aguiar, Rodrigo Barbosa
Publicado 2021

Generation and functional characterization of a single-chain variable fragment (scFv) of the anti-FGF2 3F12E7 monoclonal antibody

por de Aguiar, Rodrigo Barbosa, da Silva, Tábata de Almeida, Costa, Bruno Andrade, Machado, Marcelo Ferreira Marcondes, Yamada, Renata Yoshiko, Braggion, Camila, Perez, Kátia Regina, Mori, Marcelo Alves Silva, Oliveira, Vitor, de Moraes, Jane Zveiter
Publicado 2021